vs
Ranpak Holdings Corp.（PACK）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
Ranpak Holdings Corp.的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.6倍（$93.7M vs $60.1M），RHYTHM PHARMACEUTICALS, INC.同比增速更快（83.8% vs 2.3%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（43.8% vs 13.7%）
Ranpak Holdings Corp.主营生产防护纸质包装设备与纸制品，可为电商及各行业货品运输提供纸质缓冲包装方案，同时也供应自动化包装解决方案。公司总部位于美国俄亥俄州康科德，在美国本土多个州、捷克、荷兰、中国上海及新加坡均设有生产基地与办公室，产品可用于包裹缠绕、缓冲填隙、冷链运输等多种场景。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
PACK vs RYTM — 直观对比
营收规模更大
PACK
是对方的1.6倍
$60.1M
营收增速更快
RYTM
高出81.5%
2.3%
两年增速更快
RYTM
近两年复合增速
13.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $93.7M | $60.1M |
| 净利润 | — | $-55.6M |
| 毛利率 | 39.0% | 88.1% |
| 营业利润率 | -1.0% | -87.1% |
| 净利率 | — | -92.6% |
| 营收同比 | 2.3% | 83.8% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.11 | $-0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PACKRYTM
| Q1 26 | — | $60.1M | ||
| Q4 25 | $93.7M | $57.3M | ||
| Q3 25 | $83.6M | $51.3M | ||
| Q2 25 | $77.8M | $48.5M | ||
| Q1 25 | $77.6M | $32.7M | ||
| Q4 24 | $91.6M | $41.8M | ||
| Q3 24 | $78.6M | $33.3M | ||
| Q2 24 | $72.8M | $29.1M |
净利润PACKRYTM
| Q1 26 | — | $-55.6M | ||
| Q4 25 | — | $-47.5M | ||
| Q3 25 | $-10.4M | $-52.9M | ||
| Q2 25 | $-7.5M | $-46.6M | ||
| Q1 25 | $-10.9M | $-49.5M | ||
| Q4 24 | — | $-43.3M | ||
| Q3 24 | $-8.1M | $-43.6M | ||
| Q2 24 | $5.5M | $-32.3M |
毛利率PACKRYTM
| Q1 26 | — | 88.1% | ||
| Q4 25 | 39.0% | 91.6% | ||
| Q3 25 | 41.1% | 89.3% | ||
| Q2 25 | 37.1% | 88.6% | ||
| Q1 25 | 39.8% | 88.8% | ||
| Q4 24 | 45.2% | 90.9% | ||
| Q3 24 | 43.8% | 88.5% | ||
| Q2 24 | 43.5% | 89.9% |
营业利润率PACKRYTM
| Q1 26 | — | -87.1% | ||
| Q4 25 | -1.0% | -82.2% | ||
| Q3 25 | -6.8% | -102.6% | ||
| Q2 25 | -12.5% | -93.4% | ||
| Q1 25 | -10.3% | -143.7% | ||
| Q4 24 | 1.5% | -98.6% | ||
| Q3 24 | -5.3% | -132.0% | ||
| Q2 24 | -7.1% | -139.2% |
净利率PACKRYTM
| Q1 26 | — | -92.6% | ||
| Q4 25 | — | -83.0% | ||
| Q3 25 | -12.4% | -103.1% | ||
| Q2 25 | -9.6% | -96.1% | ||
| Q1 25 | -14.0% | -151.4% | ||
| Q4 24 | — | -103.6% | ||
| Q3 24 | -10.3% | -131.2% | ||
| Q2 24 | 7.6% | -110.9% |
每股收益（稀释后）PACKRYTM
| Q1 26 | — | $-0.83 | ||
| Q4 25 | $-0.11 | $-0.73 | ||
| Q3 25 | $-0.12 | $-0.82 | ||
| Q2 25 | $-0.09 | $-0.75 | ||
| Q1 25 | $-0.13 | $-0.81 | ||
| Q4 24 | $-0.13 | $-0.71 | ||
| Q3 24 | $-0.10 | $-0.73 | ||
| Q2 24 | $0.07 | $-0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.0M | $340.6M |
| 总债务越低越好 | $401.9M | — |
| 股东权益账面价值 | $534.9M | $122.9M |
| 总资产 | $1.1B | $442.3M |
| 负债/权益比越低杠杆越低 | 0.75× | — |
8季度趋势，按日历期对齐
现金及短期投资PACKRYTM
| Q1 26 | — | $340.6M | ||
| Q4 25 | $63.0M | $388.9M | ||
| Q3 25 | $49.9M | $416.1M | ||
| Q2 25 | $49.2M | $291.0M | ||
| Q1 25 | $65.5M | $314.5M | ||
| Q4 24 | $76.1M | $320.6M | ||
| Q3 24 | $69.5M | $298.4M | ||
| Q2 24 | $65.1M | $319.1M |
总债务PACKRYTM
| Q1 26 | — | — | ||
| Q4 25 | $401.9M | — | ||
| Q3 25 | $403.1M | — | ||
| Q2 25 | $403.1M | — | ||
| Q1 25 | $405.2M | — | ||
| Q4 24 | $406.4M | — | ||
| Q3 24 | $403.2M | — | ||
| Q2 24 | $396.1M | — |
股东权益PACKRYTM
| Q1 26 | — | $122.9M | ||
| Q4 25 | $534.9M | $139.1M | ||
| Q3 25 | $537.8M | $148.8M | ||
| Q2 25 | $539.0M | $-11.9M | ||
| Q1 25 | $544.1M | $18.9M | ||
| Q4 24 | $548.1M | $21.7M | ||
| Q3 24 | $564.3M | $11.2M | ||
| Q2 24 | $566.2M | $39.3M |
总资产PACKRYTM
| Q1 26 | — | $442.3M | ||
| Q4 25 | $1.1B | $480.2M | ||
| Q3 25 | $1.1B | $506.9M | ||
| Q2 25 | $1.1B | $372.7M | ||
| Q1 25 | $1.1B | $386.7M | ||
| Q4 24 | $1.1B | $392.3M | ||
| Q3 24 | $1.1B | $363.6M | ||
| Q2 24 | $1.1B | $381.8M |
负债/权益比PACKRYTM
| Q1 26 | — | — | ||
| Q4 25 | 0.75× | — | ||
| Q3 25 | 0.75× | — | ||
| Q2 25 | 0.75× | — | ||
| Q1 25 | 0.74× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.71× | — | ||
| Q2 24 | 0.70× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.5M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PACKRYTM
| Q1 26 | — | — | ||
| Q4 25 | $19.5M | $-25.4M | ||
| Q3 25 | $8.5M | $-26.6M | ||
| Q2 25 | $-3.6M | $-23.3M | ||
| Q1 25 | $-1.3M | $-40.4M | ||
| Q4 24 | $6.5M | $-18.8M | ||
| Q3 24 | $10.1M | $-25.2M | ||
| Q2 24 | $19.6M | $-29.1M |
现金转化率PACKRYTM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.56× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PACK
| Other | $47.9M | 51% |
| Europe And Asia Segment | $45.8M | 49% |
RYTM
暂无分部数据
